Cargando…

Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome

The aim of this study was to determine the concentration of galectin-3, PINP and PIIINP in patients with metabolic syndrome (MS) and atrial fibrillation (AF) with an assessment of the relationship with severity of left atrium fibrosis. A total of 480 subjects were included in the case-control study:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ionin, Valery A., Baranova, Elena I., Zaslavskaya, Ekaterina L., Petrishcheva, Elena Yu., Morozov, Aleksandr N., Shlyakhto, Evgeny V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461109/ https://www.ncbi.nlm.nih.gov/pubmed/32784491 http://dx.doi.org/10.3390/ijms21165689

Ejemplares similares

Relation of Procollagen Type III Amino Terminal Propeptide Level to Sepsis Severity in Pediatrics
por: Saleh, Nagwan Y., et al.
Publicado: (2021)

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
por: Gudowska, Monika, et al.
Publicado: (2017)

Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip
por: Yatsushiro, Shouki, et al.
Publicado: (2011)

Serum N‐Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism
por: Keyte, S.V., et al.
Publicado: (2016)

Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration
por: Cowan, David A., et al.
Publicado: (2021)

Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only
por: Vadon-Le Goff, Sandrine, et al.
Publicado: (2011)

Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents
por: Choi, Ji Seon, et al.
Publicado: (2019)

Renal ultrasonographic shear-wave elastography and urinary procollagen type III amino-terminal propeptide in chronic kidney disease dogs
por: Thanaboonnipat, Chutimon, et al.
Publicado: (2020)

Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults
por: Fragala, Maren S., et al.
Publicado: (2013)

Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells
Publicado: (1994)

Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease
por: Thanaboonnipat, Chutimon, et al.
Publicado: (2019)

Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19
por: Yang, Ti, et al.
Publicado: (2023)

Circulating Aminoterminal Propeptide of Type III Procollagen as a Biomarker of Cardiovascular Events in Patients Undergoing Hemodialysis
por: Nishimura, Masato, et al.
Publicado: (2019)

Visualized procollagen Iα1 demonstrates the intracellular processing of propeptides
por: Tanaka, Toshiaki, et al.
Publicado: (2022)

Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification
por: Seo, Woo-Young, et al.
Publicado: (2017)

Intra-Individual Changes in Total Procollagen-Type 1 N-terminal Propeptide in a Korean Adult Population
por: Choi, Rihwa, et al.
Publicado: (2022)

Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
por: Andersen, Thomas, et al.
Publicado: (2023)

The N-Terminal Propeptide of Type III Procollagen in Patients with Acute Coronary Syndrome: A Link between Left Ventricular End-Diastolic Pressure and Cardiovascular Events
por: Lee, Cheng-Hung, et al.
Publicado: (2015)

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Value of Procollagen Type I Aminoterminal Propeptide in Women with Breast Cancer with regard to Metastases
por: Clouth, A., et al.
Publicado: (2011)

Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction
por: Osokina, Anastasia, et al.
Publicado: (2021)

Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation
por: Yamamoto, Takanori, et al.
Publicado: (2015)

Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP()
por: Batlle, M., et al.
Publicado: (2016)

Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis
por: Wang, Yingcan, et al.
Publicado: (2020)

Serum procollagen type 1 N propeptide: A novel diagnostic test for diabetic foot osteomyelitis – A case–control study
por: Hayes, Oliver G, et al.
Publicado: (2018)

Clinical significance of serum transforming growth factor-β1 and procollagen type I N-propeptide in post-tuberculosis tracheobronchial stenosis
por: Wu, Yongchang, et al.
Publicado: (2021)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

Circulating Procollagen Type III N-Terminal Peptide and Physical Function in the Long Life Family Study
por: Santanasto, Adam, et al.
Publicado: (2020)

Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide
Publicado: (1991)

Type IIA Procollagen Containing the Cysteine-rich Amino Propeptide Is Deposited in the Extracellular Matrix of Prechondrogenic Tissue and Binds to TGF-β1 and BMP-2
por: Zhu, Yong, et al.
Publicado: (1999)

Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors
por: Zhao, Hui, et al.
Publicado: (2011)

Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Clementy, Nicolas, et al.
Publicado: (2018)

Therapeutic implications of galectin-3 in patients with atrial fibrillation
por: Lee, Kwang-No, et al.
Publicado: (2022)

Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation
por: Zhao, Fei, et al.
Publicado: (2014)

Chronobiological Analysis of Blood Pressure in a Patient with Atrial Fibrillation at the Development of Heart Failure and Its Therapeutic and Surgical Treatment
por: Chibisov, Sergey, et al.
Publicado: (2013)

Giantin is required for intracellular N-terminal processing of type I procollagen
por: Stevenson, Nicola L., et al.
Publicado: (2021)

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
por: Saarto, T., et al.
Publicado: (1998)

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation
por: Hernández-Romero, Diana, et al.
Publicado: (2017)

Propeptide glycosylation and galectin‐3 binding decrease proteolytic activation of human proMMP‐9/progelatinase B
por: Boon, Lise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_53cj6frlerc6tdcas67u2onndk